


Searching News Database: Afferent Pharmaceuticals
HSMN NewsFeed - 11 Jun 2018
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
